Skip to main content
. 2019 May 13;11:1758835919846402. doi: 10.1177/1758835919846402

Figure 3.

Figure 3.

Overall survival of 25 patients with RGCPM treated with PIPAC C/D in the salvage situation. Median survival was 6.7 months (95% CI: 2.5–12.0).

x-axis, follow up (months since first PIPAC); y-axis, cumulative survival (Kaplan–Meier).

CI, confidence interval; PIPAC C/D, pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin; RGCPM, recurrent gastric cancer with peritoneal metastasis.